Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Coen A Stegeman

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
The Journal of Rheumatology|November 3, 2005
Predictive value of antineutrophil cytoplasmic antibodies in small-vessel vasculitis: is the glass half full or half empty?Coen A Stegeman
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 28, 2002
Anti-neutrophil cytoplasmic antibody (ANCA) levels directed against proteinase-3 and myeloperoxidase are helpful in predicting disease relapse in ANCA-associated small-vessel vasculitisCoen A Stegeman
BMC Nephrology|June 27, 2023
Oxalate nephropathy in an elderly patient with newly diagnosed celiac disease - a case reportHendrik W Zijlstra, Coen A Stegeman
Clinical Kidney Journal|October 2, 2023
The elevation of the anion gap in steady state chronic kidney disease may be less prominent than generally acceptedHendrik W Zijlstra, Coen A Stegeman
Lancet (London, England)|October 12, 2004
A difficult diagnosisJan Willem Cohen Tervaert, Coen A Stegeman
Cleveland Clinic Journal of Medicine|June 28, 2002
Genetics of ANCA-associated vasculitidesCees G M Kallenberg, Agnieszka Rarok, Coen A Stegeman
Nature Medicine|October 9, 2008
Autoantibodies vex the vasculatureCees G M Kallenberg, Coen A Stegeman, Peter Heeringa
Nature Clinical Practice. Rheumatology|November 30, 2006
Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitidesCees G M Kallenberg, Peter Heeringa, Coen A Stegeman
The New England Journal of Medicine|November 25, 2003
Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodiesJan-Stephan F Sanders, Marjan C Slot, Coen A Stegeman
Current Drug Targets. Cardiovascular & Haematological Disorders|May 29, 2003
RAS blockade in experimental renal transplantation. Benefits and limitationsAnnemieke Smit-van Oosten, Coen A Stegeman, Harry van Goor
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
The Journal of Rheumatology|November 3, 2005
Predictive value of antineutrophil cytoplasmic antibodies in small-vessel vasculitis: is the glass half full or half empty?Coen A Stegeman
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 28, 2002
Anti-neutrophil cytoplasmic antibody (ANCA) levels directed against proteinase-3 and myeloperoxidase are helpful in predicting disease relapse in ANCA-associated small-vessel vasculitisCoen A Stegeman
BMC Nephrology|June 27, 2023
Oxalate nephropathy in an elderly patient with newly diagnosed celiac disease - a case reportHendrik W Zijlstra, Coen A Stegeman
Clinical Kidney Journal|October 2, 2023
The elevation of the anion gap in steady state chronic kidney disease may be less prominent than generally acceptedHendrik W Zijlstra, Coen A Stegeman
Lancet (London, England)|October 12, 2004
A difficult diagnosisJan Willem Cohen Tervaert, Coen A Stegeman
Cleveland Clinic Journal of Medicine|June 28, 2002
Genetics of ANCA-associated vasculitidesCees G M Kallenberg, Agnieszka Rarok, Coen A Stegeman
Nature Medicine|October 9, 2008
Autoantibodies vex the vasculatureCees G M Kallenberg, Coen A Stegeman, Peter Heeringa
Nature Clinical Practice. Rheumatology|November 30, 2006
Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitidesCees G M Kallenberg, Peter Heeringa, Coen A Stegeman
The New England Journal of Medicine|November 25, 2003
Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodiesJan-Stephan F Sanders, Marjan C Slot, Coen A Stegeman
Current Drug Targets. Cardiovascular & Haematological Disorders|May 29, 2003
RAS blockade in experimental renal transplantation. Benefits and limitationsAnnemieke Smit-van Oosten, Coen A Stegeman, Harry van Goor
Pageof 14